Table 1 Clinicopathological analysis of CD164 gene expression in an ovarian cancer tissue array
From: CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis
Characteristics | Total | < = 3-fold | >3-fold | p-value |
|---|---|---|---|---|
All cases | 97 | 25 (25.8%) | 72 (74.2%) | |
Age | ||||
<50 yrs | 39 | 23 (58.9%) | 16 (14.1%) | |
≥50 yrs | 58 | 34 (58.6%) | 24 (41.4%) | 0.972 |
Stage | ||||
Early (T1 + T2) | 72 | 51 (70.9%) | 21 (29.1) | |
Late (T3) | 25 | 5 (20.0%) | 34 (87%) | < 0.05 |
Grade | ||||
Low (1 & 2) | 50 | 36 (72.0%) | 14 (28.0%) | |
High (3) | 46 | 5 (10.9%) | 41 (89.1%) | < 0.001 |
Histology | ||||
Serous | 49 | 30 (61.2%) | 19 (38.8%) | |
Others | 48 | 34 (71.0%) | 14 (29.0%) | 0.317 |
Metastasis | ||||
Absent | 73 | 46 (63.1%) | 27 (36.9%) | |
Present | 24 | 8 (33.4%) | 16 (66.7%) | < 0.05 |